BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:39 PM
 | 
Sep 05, 2012
 |  BC Extra  |  Top Story

Panel backs tobramycin inhalation powder

FDA's Anti-Infective Drugs Advisory Committee voted 13-1 that Novartis AG (NYSE:NVS; SIX:NOVN) demonstrated adequate evidence of safety and evidence to support the use of tobramycin inhalation powder (formerly TOBI Podhaler) for the management of cystic...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >